Umbilical cord and cord blood-derived therapies in the treatment of ocular surface diseases: a scoping review of factors, mechanisms of action, and clinical applicability.
Umbilical cord and cord blood-derived therapies in the treatment of ocular surface diseases: a scoping review of factors, mechanisms of action, and clinical applicability. // The Ocular Surface. – URL: https://www.sciencedirect.com/science/article/pii/S1542012426001357?dgcid=rss_sd_all
Umbilical cord and cord blood-derived therapies in the treatment of ocular surface diseases: a scoping review of factors, mechanisms of action, and clinical applicability. The Ocular Surface. https://www.sciencedirect.com/science/article/pii/S1542012426001357?dgcid=rss_sd_all
“Umbilical cord and cord blood-derived therapies in the treatment of ocular surface diseases: a scoping review of factors, mechanisms of action, and clinical applicability.” The Ocular Surface.
@article{article98511,
title = {Umbilical cord and cord blood-derived therapies in the treatment of ocular surface diseases: a scoping review of factors, mechanisms of action, and clinical applicability.},
journal = {The Ocular Surface},
url = {https://www.sciencedirect.com/science/article/pii/S1542012426001357?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...